TELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Telix Pharmaceuticals Limited on Behalf of Telix Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating Telix Pharmaceuticals Limited on behalf of its stockholders due to potential violations of federal securities laws. The investigation follows Telix's disclosure of a subpoena from the SEC regarding its prostate cancer therapeutic candidates, which led to a 10.44% drop in its ADR price. Investors who suffered losses are encouraged to contact the firm for legal options.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments